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Healthcare providers recognise the value of quality improvement (QI) activities that enhance 
the care received by service users. QI is particularly effective for the management of long-term 
conditions requiring linked care. However, starting and sustaining QI programmes in practice 
can be time-consuming and difficult and may produce inconclusive and/or inconsistent results. 
As a not-for-profit social enterprise, Optimum Patient Care (OPC) has been delivering effective 
and sustainable QI since 2005 in healthcare systems in several countries. 
This paper provides a roadmap for the implementation of collaborative QI programmes in a 
range of settings across three countries. It summarises the barriers we have experienced in the 
QI cycle and solutions we have identified in our history of working with healthcare providers 
to deliver QI programmes in primary and secondary care. Key lessons include the strategic 
involvement of partners in the fields of medicine, health IT, data science and epidemiology, to 
harness, understand and act on the insights gained from patient and practice electronic health 
data (EHR) alongside crucial input from patients and practicing clinicians themselves. 
QI aims resource-poor healthcare providers to increase the precision of identifying key patient 
groups requiring further follow-up – such as those at risk of worsening health outcomes using 
risk prediction tools. Parallel goals are to increase the proportion of patients receiving prompt 
and appropriate treatment and to increase patient engagement. We achieve this by providing 
customised software tools and disease management algorithms to our healthcare partners to 
allow for automation of aspects of QI that have traditionally involved a manual process. Sharing 
our experience of these methods helps to embed a sustainable programme of QI in many 
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Introduction 
Managing chronic diseases in healthcare is challenging as patients require consistent, joined-
up support and personalised treatment over the long term1. The practice of quality 
improvement (QI) - the use of formal or informal tools to assess and improve the quality of the 
care patients receive, is a key part of optimising patient management in this setting2–4. 
Whilst there is much enthusiasm for QI as a key route to improving patient outcomes, in 
practice it can be much more difficult to implement and make routine. Central to this is the 
variability in approaches to and needs of QI4,5 and the perceived lack of time and competing 
resources required to do it well3,6. Despite a proliferation in the QI literature particularly on 
broader issues of success and sustainability7–9, there remains a gap for practical, 
implementable solutions for time-poor clinicians.  
Optimum Patient Care (OPC) is a non-profit social enterprise founded in 2005 (Figure 1), to 
work alongside healthcare providers to deliver sustainable chronic disease QI programmes. 
OPC delivers an evidence-based, guideline-driven, expert-led and general practice informed 
implementation strategy to deliver effective QI. Here we discuss the successes and lessons 





The QI Cycle: Common Barriers to Sustainable QI and Solutions 
We approach QI as a cycle of activities (Figure 2) which: first seeks to understand the context 
and needs of the healthcare setting (step 1), reflect on these needs in parallel with national or 
international standards for care (step 2), work with practitioners to set achievable and 
measurable targets (step 3), implement change (step 4), re-evaluate the care provided and 
embed QI in routine practice (step 5).  
Step 1: Current Practice 
Demonstrating the need for improvement using practice and patient data can be a persuasive 
tool to engage staff in QI6. Physicians often cite lack of buy-in or resources as reasons for poor 
engagement with QI6,7, a shortage of the skills required to harness the wealth of clinical data 
they produce8,9, and/or little understanding of how to involve patients in these processes10. To 
support practices in the assessment of the current state of care provision and potential areas 
for improvement, we have developed simple, automated tools to collect and assess data from 
electronic medical records (EMR) and patient questionnaires (patient reported 
outcomes/information – PRO/I).  
 
As data privacy is a legitimate concern, we take a strict approach to de-identifying data – we 
do not collect any practice/patient identifiers; we use irreversible hashing algorithms to 
pseudonymise patient identifiers (IDs), and in the absence of inexpensive commercial options, 
we developed a robust custom redaction tool (https://optimumpatientcare.org/redaction/) to 






Step 2: Reflect on Current Standards 
In an environment of continuously updated guidelines and “pay for performance”  funding, 
clinicians struggle to keep abreast of recommendations and best-practice11. Standards that are 
linked to financial incentives can be limited in scope, focused on a select group of patients 
where exception-reporting (exclusion of patients from formal audit or QI)12 may mean that key 
groups of excluded patients do not benefit from improved care practices.  
Using the latest guidance informed by our steering committees of clinical experts13,14, we 
summarise guidelines/standards in clear and accessible formats for practitioners, which are 
reviewed against data collected for the practice. Following feedback from the clinicians and 
experts, our programmes provide recommendations for both broad groups and individual 
patients, reflecting current, local or national guidance.  
Step 3: Establish Targets 
Like many others, we have found that setting targets for QI is a difficult, protracted process 
requiring colleagues to overcome a lack of consensus in choosing which problems to address6, 
often compounded by previous negative experiences with overambitious targets2. Our 
evolutionary approach helps to set reasonable targets by using practice and patient 
information to describe current practice, comparing this to local, national or international 
standards coupled with documented histories of achievable targets successfully implemented 
by providers in similar situations. We provide digital templates for standardised data entry, 
practice and patient level reports which are simple and clear with visualisations; summarising 
current care and recommending measurable targets for improvement. While we develop our 
own feedback system, we use pre-existing work when appropriate. An example target is the 
identification of high-risk asthma patients which may be ‘hidden’ to clinicians: We have 




on the likelihood of future asthma attacks (Figure 3) and have used the validated TargetCOPD 
algorithm to identify patients at risk of COPD19.  
Step 4: Implement Change 
We have learnt that clinicians respond well to patient stories. Patients also feel listened to 
when they are invited to see their GP after completing an OPC questionnaire, or when provided 
with an individualised report. Evidence shows that routinisation of QI activities like these is key 
to sustainability16 – thus our reports and templates are designed to be embedded in routine 
care and to support everyday clinical decision making. This process has grown out of 
experience and requires technical infrastructure and expertise, which is not always readily 
available to practices. A key lesson was to move from simply implementing systems that 
support data-driven QI, to also maintaining and developing them for the healthcare providers 
we support. 
Step 5: Re-evaluate 
An important motivator for continuing QI is the “I” - “Improvement” aspect – the ability to 
demonstrate improvement and the value of what has been achieved10,11. Assessing the impact 
or success of a QI programme is no small undertaking. Figure 2 step 5 highlights several 
reoccurring themes, summarised as a requirement for both resources and a willingness to re-
engage with the cycle. Our evaluations are time-bound to maintain momentum and are based 
on periodic re-extraction of EMR and PRO/I data and auto-generation of reports to help 
healthcare providers track their improvements. A recent evaluation of our chronic obstructive 
pulmonary disease (COPD) QI programme in UK demonstrated that practices which 




patients having a COPD exacerbation in the 12m following the start of the QI programme, 
compared to 10% reduction across all practices not actively doing QI. 
 
Conclusion 
It is increasingly recognised that healthcare practitioners, patients, the health service and the 
economy can benefit from improvements in patient care for chronic diseases. We have shown 
that large scale, collaborative QI programmes can have clear measurable benefits with little 
impact on workload7,17. Following a decade of refinement of our chronic disease QI model, we 
have learnt that working alongside primary care clinicians to integrate automated, non-
resource-intensive programmes that involve both clinic staff and patients can be a highly 
effective means to promote a long term culture of QI. 
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How this fits in with quality in primary care 
 
What do we know?  
Primary care bears much of the growing burden of the management of chronic diseases, as patients require long 
term support care and treatment(1). This can be challenging given the rise in the number of years lived with disease, 
(18) and the ever-changing evidence landscape for patient treatment. Primary care quality improvement (QI) 
programmes, the practice of assessment and improvement of the care provided to patients, can be very valuable 
in this context (1). However, implementing QI programmes can be challenging due to lack of skills, resources or will 
to see them through (3-5, 7), particularly for chronic conditions which often have complex care requirements. 
There have been numerous reviews of the barriers to effective QI programmes, with many providing general 
conceptual methods to overcome them(4,6,19). However, these often fall short of providing practical, 
implementable solutions for time-poor clinicians to whom QI may seem too big an activity to initiate and routinise. 
Optimum Patient Care is a social non-profit enterprise, with over a decade of experience in supporting healthcare 
practitioners to implement effective QI programmes. In this report, we share our lessons learnt, and successes 
achieved in carrying out sustainable QI for chronic disease management. 
What does this paper add? 
Our main messages are  
I) The effective use of clinical data does not have to be an insurmountable hurdle to good QI in poorly 
resourced healthcare settings. By engaging with external services to implement, extract and analyse 
patient and practice data, clinics can focus on the critical activities that effect change. 
II) Data privacy and security are major concerns for health services and patients, so a conservative 
approach to collecting and deanonymizing electronic medical data is recommended. The availability 
of commercial ID hashing (masking) and free-text redaction tools was low in our experience, and 
those tools that were available tended to be cost-prohibitive for a family GP practice. More 
opportunities for collaboration between academic and/or non-profit organisations with primary and 
community healthcare services can be a solution for the development of inexpensive, custom-built 
tools. 
III) Standard audits, national QI programmes and staff incentive programmes may have strict criteria 
for patients which are included in the assessment of the quality of care provided; this can lead to 
high levels of exception reporting of groups of sick patients who may therefore be excluded from 
improvement activities. Because of this, we developed our QI programmes to collect data and report 
on the outcomes for both the broad patient population, as well as for specific groups fitting criteria 
for national audit/QI programmes. 
IV) Keeping abreast of best practice in an environment of changing care standards can be difficult for a 
busy clinic. We devoted resources and time to both monitoring updates in best practice guidelines, 
but also to apply the latest academic evidence to practice – e.g. the implementation of risk 
prediction algorithms in clinical decision support tools. 
 
Most practitioners understand the advantages of embedding QI activities in routine care (routinisation), however 
achieving this can be difficult; identifying the hurdles to sustainability of QI programmes are key to understanding 
the solutions. Our experience showed that implementing time bound QI targets and assessments, and automation 
of the production of reports and of other decision support systems can increase the chances of success in effecting 
sustainable change. The paper highlights key successes using our respiratory QI programme as an example: the 
reduction in the overall risk of COPD exacerbations in practices engaging in our COPD QI programme, and the 
translation of the Respiratory Effectiveness Group asthma exacerbation risk prediction model into an accessible 














Figure 3. Application of the Respiratory Effectiveness Group (REG) algorithm to predict the risk 
of future exacerbations in patients with asthma in quality improvement programmes: Excerpt 
from an anonymised OPC UK asthma patient report showing individualised output of the 
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